Due to the pleiotropic effects of GLP-1RAs, they become the basis of a new therapeutic strategy that affects both metabolic and neuropsychiatric aspects, which is fundamentally important for the treatment of comorbid diseases
Severe vitamin B12 deficiency in pregnancy mimicking HELLP syndrome. Case Reports in Obstetrics and Gynecology 2019 (2019)
Rekha Kumar, a reproductive endocrinologist at Weill Cornell Medicine, says GLP-1 drugs wake up the ovaries, resetting the reproductive environment for normal function
Disease modifying agents capable of controlling obesity with meaningful metabolic improvement have reshaped expectations for both clinicians and patients ( Nausea and vomiting remain among the most frequent and disruptive adverse effects across Glucagon-like peptide (GLP-1)-based therapies ( In this opinion article, we examine the mechanisms underlying nausea and vomiting in semaglutide, CagriSema, survodutide, tirzepatide, retatrutide, and orforglipron and situate them within obesity clinical practice ( We also propose practical strategies to mitigate gastrointestinal intolerance
.png)
